Your browser is too old
We can't provide a great video experience on old browserUpdate now
In this lecture ´´Pharmacotherapy of Migraine´´ is explained. Section one is about ‘‘Migraine Treatment’’. Educator begins by explaining migraine. After that, talks about history of treatment. Then reveals information about treatment. Subsequently, goals of therapy are highlighted. Later on, acute attack management is discussed. Information about analgesics is also given. Following this, antiemetics comes under consideration. Next focus is on 5-HT receptor. Moreover, antimigraine mechanism of 5-HT receptors is discussed. Then ergots are pursued. Lastly, ergotamine is highlighted.
Section two is about ''Triptans''. Initially, educator explains triptans. In the next slide, sumatriptan is elaborated. Then its pharmacokinetics and adverse effects are reported. Likewise, naratriptan is discussed. This is followed zolmitriptan. Next, rizatriptan is focused. Later on, adverse effects of triptans are highlighted. Educator also notifies about drug interactions and contraindications. Furthermore, comparison of triptans is given. Afterwards, triptans and ergot alkaloids are elucidated. In the end, information about choosing triptan is conveyed.
Section three is about ''Anticonvulsants''. Earlier in this section anticonvulsants are introduced. After that topiramate is discussed. Then its pharmacokinetics is pursued. This is followed by dose and adverse effects. Moreover, zonisamide is elucidated along with its adverse effects. Subsequently, levetiracetam comes under consideration. Lastly, adverse effects and contraindications are discussed by the educator.
Section four is about ''Prophylactic Therapy''. In the beginning, educator tells about prophylactic therapy. Then prophylaxis is discussed. Following this, AAN/AHS guidelines are given. After that guidelines for migraine associated with menstruation are reported. Successful prophylaxis is the last subject of discussion.
Other Drugs and Special Conditions
Section five is about ''Other Drugs and Special Conditions''. Firstly, educator describes petasites. After that pregabalin is elucidated. Then candesartan is explained. Subsequently, migraine treatment in childhood and adolescents is thoroughly elaborated. Following this, quetiapine is discussed. Furthermore, migraine and pregnancy comes under consideration. Alongside, educator notify about novel drugs. Finally, vanilloid TRPV1 receptor antagonists are exhibited.